NOVARTIS AG-SPONSORED ADR (NVS)
US66987V1098 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 8.57B | 6.96B | 24.02B | 8.07B | 7.15B | |||
| Depreciation Amortization | 8.28B | 7.18B | 6.11B | 6.46B | 5.83B | |||
| Change In Working Capital | -4.79B | -4.30B | -3.35B | -4.73B | -2.72B | |||
| Interest Paid | 751.00M | 696.00M | 664.00M | 703.00M | 793.00M | |||
| Taxes Paid | 2.79B | 1.98B | 2.34B | 1.83B | 1.88B | |||
| Other non cash items | 2.40B | 4.40B | -11.71B | 3.84B | 3.37B | |||
| OPERATING CASH FLOW | 14.46B | 14.24B | 15.07B | 13.65B | 13.63B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.75B | -2.67B | -2.97B | -2.58B | -2.26B | |||
| Other Investing Activity | 8.35B | 4.14B | 7.18B | -10.60B | 31.00M | |||
| INVESTING CASH FLOW | 5.60B | 1.47B | 4.21B | -13.18B | -2.23B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.94B | -2.56B | -5.99B | 7.07B | -4.96B | |||
| Stock Issued/Repurchased | -8.57B | -10.55B | -3.00B | -2.09B | -5.33B | |||
| Dividend Paid | -7.25B | -7.51B | -7.37B | -6.99B | -6.64B | |||
| Other Financing Activity | 3.48B | 55.00M | 94.00M | -199.00M | 3.31B | |||
| FINANCING CASH FLOW | -14.28B | -20.56B | -16.26B | -2.21B | -13.63B | |||
| Exchange Rate Effect | 100.00M | -32.00M | -266.00M | 286.00M | 69.00M | |||
| CHANGE IN CASH | 5.88B | -4.89B | 2.75B | -1.45B | -2.16B | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 14.46B | 14.24B | 15.07B | 13.65B | 13.63B | |||
| Capital Expenditure | -2.75B | -2.67B | -2.97B | -2.58B | -2.26B | |||
| FREE CASH FLOW | 11.71B | 11.56B | 12.10B | 11.06B | 11.37B | |||
All data in USD